-
NUMBER OF INSIDER BUYING
(Last 12 Months)
1 -
NUMBER OF INSIDER SELLING
(Last 12 Months)
6 -
AMOUNT OF INSIDERS BUYING
(Last 12 Months)
$53.70 M -
AMOUNT OF INSIDERS SELLING
(Last 12 Months)
$337.75 M
Janux Therapeutics, Inc. Insider Transactions
Janux Therapeutics, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Avalon Ventures XI, L.P.
10 percent owner |
Sell | 958 @ $46.24 | $44,298 | 6,887 | 09/30/2024 | 09/30/2024 | |
|
Meyer Andrew Hollman
Chief Business Officer |
Sell | 50,000 @ $45.96 | $2.30 M | 67,592 | 09/27/2024 | 09/27/2024 | |
|
DiRaimondo Thomas
Chief Scientific Officer |
Sell | 4,325 @ $46.21 | $199,840 | 98,613 | 09/27/2024 | 09/27/2024 | |
|
DiRaimondo Thomas
Chief Scientific Officer |
Sell | 675 @ $47.22 | $31,877 | 97,938 | 09/27/2024 | 09/27/2024 | |
| Sell | 18,957 @ $46.09 | $873,715 | 313,097 | 09/27/2024 | 09/27/2024 | ||
| Sell | 5,248 @ $46.86 | $245,895 | 307,849 | 09/27/2024 | 09/27/2024 | ||
| Sell | 795 @ $47.84 | $38,032 | 307,054 | 09/27/2024 | 09/27/2024 | ||
|
Avalon Ventures XI, L.P.
10 percent owner |
Sell | 46,861 @ $46.42 | $2.18 M | 2,882,353 | 09/27/2024 | 09/30/2024 | |
|
Avalon Ventures XI, L.P.
10 percent owner |
Sell | 1,542 @ $47.74 | $73,615 | 2,880,811 | 09/27/2024 | 09/30/2024 | |
|
Avalon Ventures XI, L.P.
10 percent owner |
Sell | 45,894 @ $46.42 | $2.13 M | 2,822,981 | 09/27/2024 | 09/30/2024 | |
|
Avalon Ventures XI, L.P.
10 percent owner |
Sell | 1,511 @ $47.74 | $72,135 | 2,821,470 | 09/27/2024 | 09/30/2024 | |
|
Avalon Ventures XI, L.P.
10 percent owner |
Sell | 8,894 @ $46.42 | $412,859 | 546,833 | 09/27/2024 | 09/30/2024 | |
|
Avalon Ventures XI, L.P.
10 percent owner |
Sell | 293 @ $47.74 | $13,988 | 546,540 | 09/27/2024 | 09/30/2024 | |
|
Avalon Ventures XI, L.P.
10 percent owner |
Sell | 1,826 @ $46.19 | $84,343 | 6,926 | 09/27/2024 | 09/30/2024 | |
|
Avalon Ventures XI, L.P.
10 percent owner |
Sell | 50,539 @ $46.78 | $2.36 M | 2,970,875 | 09/26/2024 | 09/30/2024 | |
|
Avalon Ventures XI, L.P.
10 percent owner |
Sell | 41,661 @ $47.77 | $1.99 M | 2,929,214 | 09/26/2024 | 09/30/2024 | |
|
Avalon Ventures XI, L.P.
10 percent owner |
Sell | 49,497 @ $46.78 | $2.32 M | 2,909,678 | 09/26/2024 | 09/30/2024 | |
|
Avalon Ventures XI, L.P.
10 percent owner |
Sell | 40,803 @ $47.77 | $1.95 M | 2,868,875 | 09/26/2024 | 09/30/2024 | |
|
Avalon Ventures XI, L.P.
10 percent owner |
Sell | 9,592 @ $46.78 | $448,714 | 563,635 | 09/26/2024 | 09/30/2024 | |
|
Avalon Ventures XI, L.P.
10 percent owner |
Sell | 7,908 @ $47.77 | $377,765 | 555,727 | 09/26/2024 | 09/30/2024 |
Janux Therapeutics, Inc. Frequently Asked Questions
-
Who is on Janux Therapeutics, Inc.'s Insider Roster?
The list of insiders at Janux Therapeutics, Inc. includes RA CAPITAL MANAGEMENT, L.P., Avalon Ventures XI, L.P., Reardon Tighe, Lichter Jay, Campbell David Alan, DiRaimondo Thomas, Meyer Andrew Hollman.
-
How much insider selling is happening at Janux Therapeutics, Inc.?
Insiders have sold a total of 6.61 M Janux Therapeutics, Inc. shares in the last 12 months for a total of 337.75 M sold.
-
Which Janux Therapeutics, Inc. insiders have been selling company stock?
The following insiders have sold Janux Therapeutics, Inc. shares in the last 12 months: Avalon Ventures XI, L.P. ($205.38 M), Reardon Tighe ($45.04 M), Lichter Jay ($82.30 M), Campbell David Alan ($2.50 M), DiRaimondo Thomas ($231,716), Meyer Andrew Hollman ($2.30 M),
-
How much insider buying is happening at Janux Therapeutics, Inc.?
Insiders have purchased a total of 2.60 M Janux Therapeutics, Inc. shares in the last 12 months for a total of 53.70 M sold.
-
Which Janux Therapeutics, Inc. insiders have been buying company stock?
The following insiders have purchased Janux Therapeutics, Inc. shares in the last 12 months: RA CAPITAL MANAGEMENT, L.P. ($53.70 M),